Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2007
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
Asma Sultana, Catrin Tudur Smith, David Cunningham, et al.
BMC Cancer
|
July 10, 2008
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Asma Sultana, Paula Ghaneh, David Cunningham, et al.
American Journal of Surgery
|
July 22, 2008
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A Smith, Lorraine Bosonnet, Michael Raraty, et al.
Expert Review of Gastroenterology & Hepatology
|
November 7, 2014
Biomarkers for early diagnosis of pancreatic cancer
Claire Jenkinson, Julie Earl, Paula Ghaneh, et al.
Digestive Surgery
|
August 6, 2003
Pancreatic pseudocyst in chronic pancreatitis: endoscopic and surgical treatment
Edoardo Rosso, Nicholas Alexakis, Paula Ghaneh, et al.
Histopathology
|
September 3, 2009
Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
Fiona Campbell, Richard A Smith, Philip Whelan, et al.
Plos One
|
December 20, 2012
The value of source data verification in a cancer clinical trial
Catrin Tudur Smith, Deborah D Stocken, Janet Dunn, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
August 18, 2009
A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours
Nicole Sakka, Richard A Smith, Philip Whelan, et al.
The Journal of Gene Medicine
|
May 11, 2004
5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells
Christopher M Halloran, Paula Ghaneh, Susannah Shore, et al.
British Journal of Cancer
|
March 3, 2016
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
Gary Middleton, William Greenhalf, Eithne Costello, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2007
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
Asma Sultana, Catrin Tudur Smith, David Cunningham, et al.
BMC Cancer
|
July 10, 2008
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
Asma Sultana, Paula Ghaneh, David Cunningham, et al.
American Journal of Surgery
|
July 22, 2008
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A Smith, Lorraine Bosonnet, Michael Raraty, et al.
Expert Review of Gastroenterology & Hepatology
|
November 7, 2014
Biomarkers for early diagnosis of pancreatic cancer
Claire Jenkinson, Julie Earl, Paula Ghaneh, et al.
Digestive Surgery
|
August 6, 2003
Pancreatic pseudocyst in chronic pancreatitis: endoscopic and surgical treatment
Edoardo Rosso, Nicholas Alexakis, Paula Ghaneh, et al.
Histopathology
|
September 3, 2009
Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin
Fiona Campbell, Richard A Smith, Philip Whelan, et al.
Plos One
|
December 20, 2012
The value of source data verification in a cancer clinical trial
Catrin Tudur Smith, Deborah D Stocken, Janet Dunn, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
August 18, 2009
A preoperative prognostic score for resected pancreatic and periampullary neuroendocrine tumours
Nicole Sakka, Richard A Smith, Philip Whelan, et al.
The Journal of Gene Medicine
|
May 11, 2004
5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16INK4A greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells
Christopher M Halloran, Paula Ghaneh, Susannah Shore, et al.
British Journal of Cancer
|
March 3, 2016
Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
Gary Middleton, William Greenhalf, Eithne Costello, et al.
Page
of 11